Go to contents
Go to menu
°Ë»ö¾î ÀÔ·Â
Ȩ
·Î±×ÀÎ
Áñ°Üã±âÃß°¡
ENGLlSH
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Îº°°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
ÇÐȸ/Çùȸ Á¤º¸
Àú³Î Á¤º¸
Àú³Î Åõ°í ±ÔÁ¤
KMbase ¼Ò°³
°øÁö»çÇ×
¾÷µ¥ÀÌÆ® Á¤º¸
³» Á¤º¸
ÀúÀå ³í¹®
°ü½ÉºÐ¾ß ³í¹®
°ü½ÉÇÐȸ/ÇмúÁ¤º¸
¿ø¹®½Åû
°ü½ÉºÐ¾ß °ü¸®
½ºÅ©¸³Æ® ȯ°æ¿¡¼ Áö¿øµË´Ï´Ù.
³í¹®°Ë»ö
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Î°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
SITE LINK
PubMed
Google Scholar
KoreaScience
NDSL
KoreaMed
RISS
MEDLIS
Cross Check
´ëÇѾÏÇÐȸÁö
( Journal of Korean Cancer Research Association )
: °Ë»ö°á°ú :
16
  
°Ë»ö°á°ú¸ðµÎ¼±ÅÃ
1
ÀǷẸÇè Àû¿ëÀÚÀÇ ¾Ç¼ºÁ¾¾ç Áø·á½ÇÀû ºÐ¼®
Study on the Malignant Neoplasm of People Covered in the Medical Insurance Scheme
±è¿µÃ¢
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 324 ~ 336
2
º¹¸·ÈÄ°¿¡ ¹ß»ýÇÑ Endodermal Sinus Tumor
Primary Endodermal Sinus Tumor of the Retroperitoneum
¾ç½ÂºÀ
°íÇöÀ±, ¹Ú¿µÈÆ
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 317 ~ 323
3
°£ÀÇ °Å´ëÀ¶¸ð¸·¾Ï
Massive Choriocarcinoma of the Liver
¿ÕÈñÁ¤
ÀÌÇõ»ó, ¹é¾Ç¿Ï
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 312 ~ 316
4
À§ÀÇ °¡¼º¸²ÆÄÁ¾
Gastric Pseudolymphoma
Á¤ÇØÀÏ
ÃÖµ¿¿í
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 303 ~ 311
5
Á÷Àå¾ÏÀÇ ±ÙÄ¡Àû Àü¹æÀýÁ¦¼úÈÄ ¿øÀ§ºÎ ÀýÁ¦Á¤µµ, »ýÁ¸À² ¹× ±¹¼ÒÀç¹ßÀ²°úÀÇ °ü°è
The Relationship Between the Extent of Distal Clearance and Survival and Local Recurrence Rates Afte
...
³ëµ¿±Ô
¹è³²±Ô, È«±â¹æ
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 298 ~ 302
6
¹æ»ç¼±Ä¡·áÈÄ Àç¹ß¼º ¹× ÈĵξÏÀÇ ¼ö¼ú¿¡ ´ëÇÑ ÀÓ»óÀû °íÂû
Clinical Investigation of Surgery for Residual or Recurrent Cancer of the Larynx after Radiation
±è±¤Çö
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 294 ~ 297
7
´Ù¹ß¼º ÆóÀüÀ̾ÏÀÇ °í½ÄÀû ÀüÆó ¹æ»ç¼±Ä¡·á
Palliative Whole Lung Irradiation for Multiple Metastatic Lung Cancers.
Á¤Å¼ö
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 289 ~ 293
8
À§¾ÏÀÇ À§³»¹ß»ýºÎÀ§ ¹× ¼¼Æ÷ºÐȵµ¿¡ ´ëÇÑ ÀÓ»óÀû ¿¬±¸
Clinical Studies on Advanced Adenocarcinoma of the Stomach
¹Úº´Ã¤
¹èÃæ±Ù/±¸ÀÚ¿µ/À̽µµ/¼Àç°ü/¹Ú¿µÈÆ
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 283 ~ 288
9
À§¾Ï¿¡¼ÀÇ ¼ö¼úÈÄ º¸Á¶Àû ÈÇпä¹ýÀÇ È¿°ú
Effect of Adjuvant Chemotherapy Following Surgery for Stomach Cancer
Á¤´ëÇö
¹Ú¿µ¹Î, ±è¿ëö
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 278 ~ 282
10
ÁøÇàÀ§¾ÏȯÀÚ¿¡¼ High-FAMÀÇ È¿°ú
The Efficacy of High-FAM in Advanced Gastric Cancer
¹®ÇѸ²
±èÈƱ³/±èÃáÃß/À¯À翵/ÀÌ°æ½Ä/¹ÚµÎÈ£/±èºÎ¼º/±èµ¿Áý
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 272 ~ 277
11
Àڱà °æ¾Ï ȯÀÚÀÇ ¼ö¼úÈÄ NK ¼¼Æ÷ È°¼ºµµÀÇ º¯È
Postoperative Longitudinal Follow-up of Natural Killer Activity in Patients with Cervical Cancer
Á¶¼º±â
¹®Çý¼±/À±¿¬¼÷/¹Ú±âº¹/À±Åñ¸
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 263 ~ 271
12
°£´ãµµ ¹× À§Àå°ü°è ¾Ç¼ºÁ¾¾çÀÇ ¸é¿ª¼º¿¡ °üÇÑ ÀÓ»óÀû ¿¬±¸
Clinical Evaluation of Immunoparameter Study between the Hepatobiliary and Gastrointestinal Cancer
¹èÁ¾¿ì
ÃÖ¿µ·æ, ¾ö¼öÈÆ
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 255 ~ 262
13
À§ ¾Ç¼ºÁ¾¾ç¿¡ ´ëÇÑ ±¹¼Ò ImmunoglobulinÀÇ ¹ÝÀÀ
The Response of the Local Immunoglobulin System to Malignant Lesion of the Stomach
°íÀçÇÐ
¹è³²±Ô, È«±â¹æ
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 250 ~ 254
14
FAMº´¿ëÈÇпä¹ýÁ¦ÀÇ LiposomesÀÌ¿ëÀÇ ½ÇÇèÀû ¿¬±¸
Experimental Studies on the Tumor Chemotheraphy of FAM Encapsulated with Liposomes
·ù·æ¿î
°Å¿õ/À±Å¹¿µ/·ù¿¬Çö
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 245 ~ 249
15
ÀÎü ´ëÀå ¼±¾ÏÀ¯·¡ ¼¼Æ÷ÁÖ(SC-I)ÀÇ ¹è¾ç ¼ö¸³
Establishment of Cell Line(SC-I) Derived from Human Colon Adenocarcinoma
¹ÚÀç°©
·®´ëÇö/±èÁ¤ÅÃ/·®Çѱ¤/±èÁøº¹/¹®½Å¿ë/±è¿ìÈ£/±è¿ëÀÏ
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 233 ~ 244
16
ÀÎü À§ ¼±¾ÏÀ¯·¡ ¼¼Æ÷ÁÖ(SS-I)ÀÇ ´©µå ¸¶¿ì½º À̽Ä
Heterotransplatation of Cell Line (SS-I) derived from Human Stomach Adenocarcinoma in Athymic Nude M
...
±èÁøº¹
¹ÚÀç°©/·®Çѱ¤/Â÷â·æ/¹®½Å¿ë/±è¿ìÈ£/±èÀÏÈ£/Àå¿ìÇö/À̹®È£
´ëÇѾÏÇÐȸÁö
1984³â 16±Ç 2È£ 229 ~ 232